NCT06971575 Cervical Radiculopathy Imaging Using MRN With Electrodiagnostic Correlation
| NCT ID | NCT06971575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital for Special Surgery, New York |
| Condition | Cervical Radiculopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-10-24 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2023-10-24 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will study patients with cervical radiculopathy. We will evaluate the combined diagnostic and prognostic value of magnetic resonance neurography (MRN), electrodiagnostic (EDX) studies, and historical and physical clinical elements. Specifically, this project will explore whether these data individually or in combination correlate with response to procedural and non-procedural treatment.
Eligibility Criteria
Inclusion Criteria: * Patients presenting with symptoms compatible with acute or subacute unilateral (one-sided) cervical radiculopathy and signs of clinical weakness * 18-60 years old at the time of evaluation * Symptom onset of 2 to 12 weeks leading up to baseline visit * Diagnosis of unilateral cervical radiculopathy, with or without spinal cord compression, based on signs and symptoms, physical exam and supported by MRI findings of radiculopathy (as evidenced by foraminal stenosis/narrowing) based on standard-of-care cervical spine MRI * Patients who have undergone or have planned electrodiagnostic testing at HSS prior to surgery Exclusion Criteria: * Prior cervical surgery or instrumentation * Those who have had a prior episode of cervical radiculopathy * History of peripheral neuropathy or another acute or chronic neurodegenerative condition * History of stroke, cerebellar disease, or central nervous system disease * Contraindications to undergoing a standard MRI examination (e.g., pregnancy) * Patients presenting with bilateral cervical radiculopathy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06971575 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Cervical Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06971575 currently recruiting?
Yes, NCT06971575 is actively recruiting participants. Contact the research team at chazenjl@hss.edu for enrollment information.
Where is the NCT06971575 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06971575 clinical trial?
NCT06971575 is sponsored by Hospital for Special Surgery, New York. The trial plans to enroll 20 participants.